======= PFKL ======= == Gene Information == * **Official Symbol**: PFKL * **Official Name**: phosphofructokinase, liver type * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5211|5211]] * **UniProt**: [[https://www.uniprot.org/uniprot/P17858|P17858]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PFKL&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PFKL|Open PubMed]] * **OMIM**: [[https://omim.org/entry/171860|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the liver (L) subunit of an enzyme that catalyzes the conversion of D-fructose 6-phosphate to D-fructose 1,6-bisphosphate, which is a key step in glucose metabolism (glycolysis). This enzyme is a tetramer that may be composed of different subunits encoded by distinct genes in different tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]. * **UniProt Summary**: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. {ECO:0000255|HAMAP-Rule:MF_03184, ECO:0000269|PubMed:22923583}. |PFK| |6-phosphofructokinase complex| |6-phosphofructokinase activity| |fructose binding| |fructose-6-phosphate binding| |fructose 6-phosphate metabolic process| |fructose 1,6-bisphosphate metabolic process| |AMP binding| |monosaccharide binding| |NADH regeneration| |glucose catabolic process to pyruvate| |canonical glycolysis| |glycolytic process through glucose-6-phosphate| |glycolytic process through fructose-6-phosphate| |glucose catabolic process| |NADH metabolic process| |negative regulation of insulin secretion| |glycolytic process| |ATP generation from ADP| |negative regulation of peptide hormone secretion| |NAD metabolic process| |ADP metabolic process| |hexose catabolic process| |nucleoside diphosphate phosphorylation| |purine ribonucleoside diphosphate metabolic process| |nucleotide phosphorylation| |purine nucleoside diphosphate metabolic process| |monosaccharide catabolic process| |negative regulation of hormone secretion| |ribonucleoside diphosphate metabolic process| |pyruvate metabolic process| |nucleoside diphosphate metabolic process| |kinase binding| |protein homotetramerization| |glucose metabolic process| |secretory granule lumen| |carbohydrate catabolic process| |ficolin-1-rich granule lumen| |negative regulation of protein secretion| |response to glucose| |negative regulation of peptide secretion| |response to hexose| |response to monosaccharide| |protein tetramerization| |hexose metabolic process| |response to carbohydrate| |regulation of insulin secretion| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |monosaccharide metabolic process| |negative regulation of secretion by cell| |ATP metabolic process| |regulation of peptide hormone secretion| |negative regulation of secretion| |regulation of hormone secretion| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |protein homooligomerization| |purine-containing compound metabolic process| |generation of precursor metabolites and energy| |small molecule catabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |regulation of protein secretion| |carbohydrate metabolic process| |negative regulation of transport| |neutrophil degranulation| |neutrophil activation involved in immune response| |regulation of peptide secretion| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |protein complex oligomerization| |myeloid cell activation involved in immune response| |monocarboxylic acid metabolic process| |regulation of hormone levels| |nucleobase-containing small molecule metabolic process| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |leukocyte mediated immunity| |exocytosis| |regulation of secretion| |organophosphate metabolic process| |carboxylic acid metabolic process| |leukocyte activation| |oxidation-reduction process| |oxoacid metabolic process| |secretion by cell| |organic acid metabolic process| |carbohydrate derivative metabolic process| |regulation of protein localization| |export from cell| |identical protein binding| |cell activation| |immune effector process| |secretion| |phosphorylation| |negative regulation of cell communication| |negative regulation of signaling| |ATP binding| |response to oxygen-containing compound| |protein-containing complex assembly| |small molecule metabolic process| |organic substance catabolic process| |protein-containing complex subunit organization| |regulation of transport| |immune response| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2692 * **Expression level (log2 read counts)**: 7.67 {{:chemogenomics:nalm6 dist.png?nolink |}}